Chinese medicine pentacyclic triterpene celastrol ameliorates inflammation, metabolic dysfunctions and insulin resistance in diet-induced obesity via covalently modifying endoplasmic reticulum chaperone GRP78


Grant Data
Project Title
Chinese medicine pentacyclic triterpene celastrol ameliorates inflammation, metabolic dysfunctions and insulin resistance in diet-induced obesity via covalently modifying endoplasmic reticulum chaperone GRP78
Principal Investigator
Professor Rong, Jianhui   (Principal Investigator (PI))
Co-Investigator(s)
Professor Li Xuechen   (Co-Investigator)
Professor Wang Yu   (Co-Investigator)
Dr Xia Zhengyuan   (Co-Investigator)
Duration
42
Start Date
2020-01-01
Completion Date
2023-06-30
Amount
928117
Conference Title
Chinese medicine pentacyclic triterpene celastrol ameliorates inflammation, metabolic dysfunctions and insulin resistance in diet-induced obesity via covalently modifying endoplasmic reticulum chaperone GRP78
Keywords
Chaperone GRP78, Chinese medicine celastrol, ER stress, Molecular mechanism, Obesity
Discipline
Traditional Chinese Medicine (basic)Pharmacology/Toxicology
Panel
Biology and Medicine (M)
HKU Project Code
17119619
Grant Type
General Research Fund (GRF)
Funding Year
2019
Status
Completed
Objectives
1 To elucidate the formation of celastrol-GRP78 conjugate and subsequent effects on chaperone activity and unfolded protein degradation. GRP78 senses unfolded proteins and activates ER stress signalling pathways. We for the first time discovered the formation of covalent celastrol-GRP78 conjugate. Covalent celastrol-GRP78 conjugation may help the control of unfolded protein response against lipidotoxicity. We will determine the molecular basis of celastrol-GRP78 conjugation and the potential effects on the chaperone activity and unfolded protein degradation. 2 To determine the effects of celastrol-GRP78 conjugation on unfolded protein responses, ER stress sensing and ER-phagy. Obesity promotes the accumulation of unfolded proteins, regulates GRP78 chaperone activity and thereby induces ER stress. Our pilot results demonstrated that celastrol attenuated palmitate-induced activation of ATF6, IRE1α and PERK. Thus, the present study will determine whether celastrol-GRP78 conjugation could not only prevent the activation of ER stress signalling pathways but also activate ER-phagy towards the resolution of unfolded proteins. 3 To discover the structure-activity relationship towards the development of specific GRP78 inhibitors. Celastrol may bind several different protein targets. Thus, this project was designed to determine whether celastrol primarily targets GRP78 against obesity and discover the structural elements for specific binding to GRP78. We performed virtual screening and developed a synthetic procedure for preparing 6-substituted celastrol derivatives. We will further determine celastrol derivatives against ER stress, inflammation, lipid metabolism and insulin resistance.